The peripheral blood inflammatory markers may predict response to nivolumab for advanced renal cell carcinoma
2007 ◽
Vol 177
(4S)
◽
pp. 429-430
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):